Papers - TOKUDA Emi
-
Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors.
Izumi K, Iyoda T, Yokota A, Kanno M, Hoshi M, Tokuda E, Sasaki E, Kanazawa K, Kuroda J, Saji S.
Support Care Cancer. 32 ( 11 ) 735 2024.10
-
Ⅱバイオロジー,基礎研究の進歩 6 女性ホルモン依存性の分子機構とその耐性獲得
徳田 恵美
日本臨床 82 ( 増刊6 ) 64 - 70 2024.9（ ISSN:0047-1852 ）
-
Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.
Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S.
Immunotherapy. 2024.6
-
Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S
Immunotherapy 1 - 10 2024.6（ ISSN:1750-743X ）
-
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer.
Ishizuka Y, Horimoto Y, Morita M, Kawamura Y, Sekine K, Obayashi S, Kojima Y, Tokuda E, Higuchi T, Shimomura A.
Cancer Diagn Progn. 3 ( 6 ) 678 - 686 2023.11
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Terada M, Ito A, Kikawa Y, Koizumi K, Naito Y, Shimoi T, Ishihara M, Yamanaka T, Ozaki Y, Hara F, Nakamura R, Hattori M, Miyashita M, Kondo N, Yoshinami T, Takada M, Matsumoto K, Narui K, Sasada S, Iwamoto T, Hosoda M, Takano Y, Oba T, Sakai H, Murakami A, Higuchi T, Tsuchida J, Tanabe Y, Shigechi T, Tokuda E, Harao M, Kashiwagi S, Mase J, Watanabe J, Nagai SE, Yamauchi C, Yamamoto Y, Iwata H, Saji S, Toyama T.
Breast Cancer. 2023.11
-
Natori Y, Suga J, Tokuda E, Tachibana K, Imai J, Honma R, Azami Y, Noda M, Sasaki E, Watanabe S, Ohtake T, Saji S.
Cancers 15 ( 2 ) 539 - 539 2023.1（ ISSN:2072-6694 ）
-
Successful management of pelvic recurrence of MSI-High endometrial cancer by total pelvic exenteration followed by administration of pembrolizumab:A case report.
Kojima M, Soeda S, Okabe C, Sato T, Kamo N, Ueda M, Endo Y, Nomura S, Tokuda E, Furukawa S, Kataoka M, Fujita S, Saji S, Watanabe T, Fujimori K.
Fukushima J Med Sci. 15 ( 2 ) 539 2022.12
-
Is adjuvant chemotherapy necessary in older patients with breast cancer?
Morita M, Shimomura A, Tokuda E, Horimoto Y, Kawamura Y, Ishizuka Y, Sekine K, Obayashi S, Kojima Y, Uemura Y, Higuchi T.
Breast Cancer. 29 ( 3 ) 498 - 506 2022.5（ ISSN:1340-6868 ）
-
Everolimus+Exemestane療法後に腫瘍崩壊症候群をきたした進行乳癌の一例
竹村 真生子, 岡崎 護, 羽成 直行, 徳田 恵美, 田辺 真彦, 林 嗣博, 水谷 知央, 林 孝朗, 中村 優飛, 根本 悠里, 佐久間 芽衣, 叶多 諒, 萩尾 浩太郎, 絹田 俊爾, 山口 佳子, 輿石 直樹
福島医学雑誌 71 ( 1 ) 35 - 40 2021.4（ ISSN:0016-2582 ）
-
Everolimus+Exemestane療法後に腫瘍崩壊症候群をきたした進行乳癌の一例
竹村 真生子, 岡崎 護, 羽成 直行, 徳田 恵美, 田辺 真彦, 林 嗣博, 水谷 知央, 林 孝朗, 中村 優飛, 根本 悠里, 佐久間 芽衣, 叶多 諒, 萩尾 浩太郎, 絹田 俊爾, 山口 佳子, 輿石 直樹
福島医学雑誌 71 ( 1 ) 35 - 40 2021.4（ ISSN:0016-2582 ）
-
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.
Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S
Journal for immunotherapy of cancer 8 ( 2 ) 2020.10
-
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
Iida Masafumi, Toyosawa Daichi, Nakamura Misato, Tsuboi Kouki, Tokuda Emi, Niwa Toshifumi, Ishida Takanori, Hayashi Shin-ichi
Breast Cancer 27 ( 5 ) 963 - 972 2020.9（ ISSN:1340-6868 ）
-
Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
Horimoto Yoshiya, Hlaing May Thinzar, Saeki Harumi, Kitano Shigehisa, Nakai Katsuya, Sasaki Ritsuko, Kurisaki-Arakawa Aiko, Arakawa Atsushi, Otsuji Naomi, Matsuoka Shuji, Tokuda Emi, Arai Masami, Saito Mitsue
Cancer Science 111 ( 7 ) 2647 - 2654 2020.7（ ISSN:1347-9032 ）
-
分子標的治療薬の副作用と支持療法 CDK4/6阻害薬
徳田 恵美
腫瘍内科 25 ( 3 ) 257 - 264 2020.3
-
食道狭窄をきたした高齢者転移性乳癌に集学的治療が著効した1例
魚森 俊喬, 徳田 恵美, 堀本 義哉, 齊藤 光江
日本外科系連合学会誌 44 ( 6 ) 1031 - 1035 2019.12（ ISSN:0385-7883 ）
-
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M, Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Saito M.
Med Oncol. 36 ( 10 ) 89 2019.9
-
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M, Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Saito M
Medical oncology (Northwood, London, England) 36 ( 10 ) 89 2019.9（ ISSN:1357-0560 ）
-
The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer.
Iida M, Nakamura M, Tokuda E, Toyosawa D, Niwa T, Ohuchi N, Ishida T, Hayashi SI
Oncotarget. 10 ( 47 ) 4907 - 4918 2019.8
-
【エストロゲン受容体陽性転移乳癌の薬物療法】CDK4/6阻害薬
徳田 恵美, 佐治 重衡
日本内分泌外科学会誌 36 ( 2 ) 101 - 106 2019.6